z-logo
open-access-imgOpen Access
Gambaran Makroskopis Persembuhan Luka Mukosa Buccal Tikus Putih (Rattus norvegicus) Pascapemberian Policresulen
Author(s) -
Tri Isyani Tunggadewi,
Tony Wahyudi,
Aisyah Alviatus Shofwan,
Anggri Azhari Khoerunnisa,
Huda Shalahudin Darusman
Publication year - 2021
Publication title -
arshi veterinary letters
Language(s) - English
Resource type - Journals
ISSN - 2581-2416
DOI - 10.29244/avl.4.3.57-58
Subject(s) - medicine , buccal administration , wound healing , swelling , buccal mucosa , surgery , pathology , dentistry , oral cavity
This study aimed to investigate the effect of policresulen treatment with various concentrations on the wound healing in buccal mucosa of white rats (Rattus norvegicus) through macroscopically observation. The number of 54 rats were divided into six treatment groups policresulen with concentration of 36%, 10%, 5%, 1%, 0.3% and one control group. The buccal mucosal injury was made with a 0.5 cm biopsy punch. The treatment of mucosal injury was conducted by dropped policresulen on the 2nd day until the 5th day after the injury. Macroscopic observation under a stereo micro-scope was conducted on the wound diameter, redness, swelling, and necrose. The results showed that wound healing was influenced significantly with concentration of the policresulen. The best healing was shown on lowest concentration marked which has lowest size of the wound diameter (0.50 ± 0.00 cm), the lowest tissue redness (0.00 ± 0.00), lowest final swelling at a concentration of 0.3%. Clinical evaluation of wound tissue necrose parameters which were seen to be most severe at 10% policresulen administration followed by 36% concentration and the least necrose shown on policresulen administration 0.3%. Therefore, based on macroscopic images with parameters of wound diameter, redness, swelling, and necrose suggested that policresulen used for wound healing process are at a concentration of 0.3%.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here